Cite

HARVARD Citation

    Jung, M. et al. (2022). Nanovesicle‐Mediated Targeted Delivery of Immune Checkpoint Blockades to Potentiate Therapeutic Efficacy and Prevent Side Effects. Advanced materials. 34 (9), p. n/a. [Online]. 
  
Back to record